Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation ...
For instance, some products that are used to perform various in vitro diagnostic tests using various technologies involve real time PCR detection systems, immunoassay systems, and others. In vitro ...
Philip Awadalla has been studying population genetics for decades, and is still amazed at what scientists have learned from comparing genomes at scale. “There have been massive advancements in our ...
Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...
Circulating tumor DNA may be an effective biomarker for stratifying patients with small cell lung cancer who would benefit from more stringent follow-ups and clinical trial participation.Patients who ...
Synthetic Oligonucleotides are set for rapid expansion in healthcare, food production, and data storage. The technology, vital in both existing and new markets, promises vast growth potential often ...
DNA microarrays, comprising spotted PCR products of 0.6 Kb or above, have become a major platform for functional genomics. It is considered that array performance could be improved by turning to ...
Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Treated With Cyclin-Dependent Kinase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results